Literature DB >> 26702927

The transglutaminase type 2 and pyruvate kinase isoenzyme M2 interplay in autophagy regulation.

Sara Altuntas1, Federica Rossin1, Claudia Marsella1, Manuela D'Eletto1, Laura Diaz-Hidalgo1, Maria Grazia Farrace1, Michelangelo Campanella1,2, Manuela Antonioli1, Gian Maria Fimia3,4, Mauro Piacentini1,3.   

Abstract

Autophagy is a self-degradative physiological process by which the cell removes worn-out or damaged components. Constant at basal level it may become highly active in response to cellular stress. The type 2 transglutaminase (TG2), which accumulates under stressful cell conditions, plays an important role in the regulation of autophagy and cells lacking this enzyme display impaired autophagy/mitophagy and a consequent shift their metabolism to glycolysis. To further define the molecular partners of TG2 involved in these cellular processes, we analysed the TG2 interactome under normal and starved conditions discovering that TG2 interacts with various proteins belonging to different functional categories. Herein we show that TG2 interacts with pyruvate kinase M2 (PKM2), a rate limiting enzyme of glycolysis which is responsible for maintaining a glycolytic phenotype in malignant cells and displays non metabolic functions, including transcriptional co-activation and protein kinase activity. Interestingly, the ablation of PKM2 led to the decrease of intracellular TG2's transamidating activity paralleled by an increase of its tyrosine phosphorylation. Along with this, a significant decrease of ULK1 and Beclin1 was also recorded, thus suggesting a block in the upstream regulation of autophagosome formation. These data suggest that the PKM2/TG2 interplay plays an important role in the regulation of autophagy in particular under cellular stressful conditions such as those displayed by cancer cells.

Entities:  

Keywords:  Beclin1; LC3; autophagy; pyruvate kinase M2; transglutaminase type 2

Mesh:

Substances:

Year:  2015        PMID: 26702927      PMCID: PMC4792602          DOI: 10.18632/oncotarget.6759

Source DB:  PubMed          Journal:  Oncotarget        ISSN: 1949-2553


  62 in total

Review 1.  The role of tissue transglutaminase in cell-matrix interactions.

Authors:  Evgeny A Zemskov; Anna Janiak; Jun Hang; Anu Waghray; Alexey M Belkin
Journal:  Front Biosci       Date:  2006-01-01

2.  The basal proton conductance of mitochondria depends on adenine nucleotide translocase content.

Authors:  Martin D Brand; Julian L Pakay; Augustine Ocloo; Jason Kokoszka; Douglas C Wallace; Paul S Brookes; Emma J Cornwall
Journal:  Biochem J       Date:  2005-12-01       Impact factor: 3.857

Review 3.  The role of transglutaminase-2 and its substrates in human diseases.

Authors:  Francesco Facchiano; Antonio Facchiano; Angelo M Facchiano
Journal:  Front Biosci       Date:  2006-05-01

4.  Tissue transglutaminase inhibits autophagy in pancreatic cancer cells.

Authors:  Ugur Akar; Bulent Ozpolat; Kapil Mehta; Jansina Fok; Yasuko Kondo; Gabriel Lopez-Berestein
Journal:  Mol Cancer Res       Date:  2007-03       Impact factor: 5.852

Review 5.  The diversity of the DnaJ/Hsp40 family, the crucial partners for Hsp70 chaperones.

Authors:  X-B Qiu; Y-M Shao; S Miao; L Wang
Journal:  Cell Mol Life Sci       Date:  2006-11       Impact factor: 9.261

Review 6.  Transglutaminase 2: an enigmatic enzyme with diverse functions.

Authors:  Laszlo Fesus; Mauro Piacentini
Journal:  Trends Biochem Sci       Date:  2002-10       Impact factor: 13.807

Review 7.  Transglutaminase 2 inhibitors and their therapeutic role in disease states.

Authors:  Matthew Siegel; Chaitan Khosla
Journal:  Pharmacol Ther       Date:  2007-05-13       Impact factor: 12.310

Review 8.  Autophagy and the integrated stress response.

Authors:  Guido Kroemer; Guillermo Mariño; Beth Levine
Journal:  Mol Cell       Date:  2010-10-22       Impact factor: 17.970

9.  "Tissue" transglutaminase contributes to the formation of disulphide bridges in proteins of mitochondrial respiratory complexes.

Authors:  Pier Giorgio Mastroberardino; Maria Grazia Farrace; Irene Viti; Flaminia Pavone; Gian Maria Fimia; Gennaro Melino; Carlo Rodolfo; Mauro Piacentini
Journal:  Biochim Biophys Acta       Date:  2006-08-03

Review 10.  Decoding Warburg's hypothesis: tumor-related mutations in the mitochondrial respiratory chain.

Authors:  Jose M Garcia-Heredia; Amancio Carnero
Journal:  Oncotarget       Date:  2015-12-08
View more
  11 in total

1.  Glycolysis regulated transglutaminase 2 activation in cardiopulmonary fibrogenic remodeling.

Authors:  Chinmayee D Bhedi; Sabina Nasirova; Deniz Toksoz; Rod R Warburton; Kevin J Morine; Navin K Kapur; Jonas B Galper; Ioana R Preston; Nicholas S Hill; Barry L Fanburg; Krishna C Penumatsa
Journal:  FASEB J       Date:  2019-11-28       Impact factor: 5.191

2.  Genistein antagonizes gliadin-induced CFTR malfunction in models of celiac disease.

Authors:  Speranza Esposito; Valeria Rachela Villella; Eleonora Ferrari; Romina Monzani; Antonella Tosco; Federica Rossin; Manuela D'Eletto; Alice Castaldo; Alessandro Luciani; Marco Silano; Gianni Bona; Gian Luigi Marseglia; Luigina Romani; Mauro Piacentini; Valeria Raia; Guido Kroemer; Luigi Maiuri
Journal:  Aging (Albany NY)       Date:  2019-04-12       Impact factor: 5.682

3.  TG2 regulates the heat-shock response by the post-translational modification of HSF1.

Authors:  Federica Rossin; Valeria Rachela Villella; Manuela D'Eletto; Maria Grazia Farrace; Speranza Esposito; Eleonora Ferrari; Romina Monzani; Luca Occhigrossi; Vittoria Pagliarini; Claudio Sette; Giorgio Cozza; Nikolai A Barlev; Laura Falasca; Gian Maria Fimia; Guido Kroemer; Valeria Raia; Luigi Maiuri; Mauro Piacentini
Journal:  EMBO Rep       Date:  2018-05-11       Impact factor: 8.807

4.  Autophagy activation and photoreceptor survival in retinal detachment.

Authors:  Jianhui Xiao; Jingyu Yao; Lin Jia; Thomas A Ferguson; Sarah Weber; Jeffrey M Sundstrom; Thomas J Wubben; Cagri G Besirli; David N Zacks
Journal:  Exp Eye Res       Date:  2021-02-18       Impact factor: 3.467

Review 5.  The Multifaceted Role of HSF1 in Pathophysiology: Focus on Its Interplay with TG2.

Authors:  Luca Occhigrossi; Manuela D'Eletto; Nickolai Barlev; Federica Rossin
Journal:  Int J Mol Sci       Date:  2021-06-14       Impact factor: 5.923

6.  Ribose 5-phosphate isomerase inhibits LC3 processing and basal autophagy.

Authors:  Jacob Heintze; Joana R Costa; Melanie Weber; Robin Ketteler
Journal:  Cell Signal       Date:  2016-06-18       Impact factor: 4.315

Review 7.  Changing perspective on oncometabolites: from metabolic signature of cancer to tumorigenic and immunosuppressive agents.

Authors:  Mauro Corrado; Luca Scorrano; Silvia Campello
Journal:  Oncotarget       Date:  2016-07-19

8.  A pathogenic role for cystic fibrosis transmembrane conductance regulator in celiac disease.

Authors:  Valeria R Villella; Andrea Venerando; Giorgio Cozza; Speranza Esposito; Eleonora Ferrari; Romina Monzani; Mara C Spinella; Vasilis Oikonomou; Giorgia Renga; Antonella Tosco; Federica Rossin; Stefano Guido; Marco Silano; Enrico Garaci; Yu-Kai Chao; Christian Grimm; Alessandro Luciani; Luigina Romani; Mauro Piacentini; Valeria Raia; Guido Kroemer; Luigi Maiuri
Journal:  EMBO J       Date:  2018-11-29       Impact factor: 11.598

9.  Infection-driven activation of transglutaminase 2 boosts glucose uptake and hexosamine biosynthesis in epithelial cells.

Authors:  Benoit Maffei; Marc Laverrière; Yongzheng Wu; Sébastien Triboulet; Stéphanie Perrinet; Magalie Duchateau; Mariette Matondo; Robert L Hollis; Charlie Gourley; Jan Rupp; Jeffrey W Keillor; Agathe Subtil
Journal:  EMBO J       Date:  2020-03-05       Impact factor: 11.598

10.  Identifying transglutaminase reaction products via mass spectrometry as exemplified by the MUC2 mucin - Pitfalls and traps.

Authors:  Liisa Arike; Gunnar C Hansson; Christian V Recktenwald
Journal:  Anal Biochem       Date:  2020-03-25       Impact factor: 3.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.